Dr. Cosman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 S Route 9w
Helen Hayes Hospital
West Haverstraw, NY 10993Phone+1 845-786-4494Fax+1 845-787-4878
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1983 - 1988
- Stony Brook University Health Sciences Center School of MedicineClass of 1983
Certifications & Licensure
- NY State Medical License 1985 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Hudson Valley Magazine Castle Connolly, 2007-2013
- New York Magazine: Top Doctors Castle Connolly, 2002
Clinical Trials
- Parathyroid Hormone (PTH) With Alendronate for Osteoporosis Start of enrollment: 1987 Sep 01
- Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur Start of enrollment: 2010 Aug 01
- The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- 84 citationsSpine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (...Felicia Cosman, John H. Krege, Anne C. Looker, John T. Schousboe, Bo Fan
Osteoporosis International. 2017-02-07 - 2390 citationsClinician’s Guide to Prevention and Treatment of OsteoporosisFelicia Cosman, S. J. de Beur, Meryl S. LeBoff, E. M. Lewiecki, B. Tanner
Osteoporosis International. 2014-08-15 - 5 citationsTreatment Sequence for Osteoporosis.Felicia Cosman, Bente Langdahl, Benjamin Z Leder
Endocrine Practice. 2024-05-01
Authored Content
- Abaloparatide: An Anabolic Treatment to Reduce Fracture Risk in Postmenopausal Women with OsteoporosisOctober 2020
Press Mentions
- Highlights from the ACR Review Course 2022December 6th, 2022
- Conference aids2022 HighlightsOctober 27th, 2022
- ACR 2020: 100+ Arthritis and Rheumatic Disease Updates Patients Must Know AboutNovember 25th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: